
CLL: Hematologists Face Off on Best Long-Term Strategy
In the age of targeted therapy, what’s the best long-term strategy to treat chronic lymphocytic leukemia (CLL), the most common leukemia in Western countries? Should treatment be continuous to achieve deep remissions or time-limited to allow patients to …